LMNA and cardiomyopathy: We propose that patients with laminopathic lipodystrophy, whatever their underlying LMNA pathogenic variant, should be systematically investigated with 24-h ECG monitoring, echocardiography and/or cardiac MRI for the diagnosis of cardiomyopathy, and stress test and/or coronary CT angiogram to detect coronary artery disease.